HHS

Tiaan

Why do you think it's not priced in? Pricing in happens before the news is confirmed. MSOS is up over 100% since we got news of the rescheduling recommendation from HHS back in Aug of last year. CGC is up over 400% from its all time lows a few months ago. We've only dumped since confirming S3 on Tuesday. It sucks but if this isn't evidence of "rescheduling being priced in" idk what it is.

Wan4trulove

Natalie FWIW is a journalist and a skeptic , she knows the bureaucratic red tape and how processes can drag on for years , but this is different , HHS completed the review in 10 months and DEA in just 8 months which is unprecedented (Remember they could've pushed this into years). So , by looking at everything , Biden wants this before election and things are moving in that direction. So , there is a high probability that we will get a final ruling by first half of October.

roloplex

No. Cannabis is regulated under the CSA. Congress would have to act to remove it or the DEA / HHS would need to go through the process which they are doing now. The president can't do an executive order to negate legislation on his own.

OkayShill

These are separate legislative acts and are different from the HHS / DEA's rescheduling announcement.

ItinerantDrifter

Yeah… pretty wild. It looks like Friday really began to separate from the pack in Sep 2023 after the HHS letter…but even well before then the pattern was very noticeable.

DirtyBirdie99

Right, so Biden ordered it, HHS said sched 3, DEA agrees, and OMB is gonna shoot it down? Not a chance…. Like 0%

Livid-Character-9830

What reality? What have HHS and DEA done ?

BloominVeg

Hmmm there's an election every two years hmmm. He appointed cannabis friendly DEA and HHS heads right after taking office hmmmm hmmmmm. You must be a researcher hmmmm hmmmm

BloominVeg

you think reality is funny. maybe you missed what the HHS and DEA have done.

BloominVeg

you're absolutely wrong. the HHS head was appointed by Biden

Kutukuprek

The rollercoaster continues. I don’t like it any more than any of you do but for those with an investment mindset, today was an opportunity to buy. If we take a step back, the financials of the biggest companies in the space, if legitimized, should probably be 2-3x the current prices. As a 7 year long investor (and massive bag holder) in the space, I had much bigger worries the last couple years — whether it’ll be legitimized at all.. in this decade or maybe even my lifetime. The recent moves are historic and is a critical step in legitimizing US MSOs. So that worry has been rested, it’s now a much more tangible time horizon and I think everything including uplisting is likely to happen within the next 4 years (assuming Biden is re-elected). Super frustrating day, but at least the whole HHS/DEA thing from end of last year wasn’t a false dawn. It’s actually panning out. That was probably the real biggest worry of everyone who’s long in the space.

bananastock

Last time we had a 13% pull back after HHS S3 intra day. Then, after several hours of flagging we went up the next day.

infinite_cura

was it red the day after the HHS announcement last year?

More_Advertising_383

Day of HHS leak in August MSOS +21%, next day +15% with a slow grind to just over a 100% gain in two weeks. Yesterday +25%, midday today -9%. I hope you’re right.

bananastock

HHS Scheudle 3 was known. Because Anne was appointed by Biden, it was assumed they would agree with S3. I like to think of yesterday as something that was known/assumed which why short term traders who accumulated the last few months are selling the fuck out of their quick gains.

ChungusSpliffs

Shit makes no sense, we went higher when HHS suggested S3

SmellsLikeMids

Just based on a Biden winning the presidency we saw a massive spike and slow sell off, and for HHS recommendation we saw a smaller spike and then sell off. The most recent one is smaller than those two but we’re also expecting a concrete response in the next few weeks. If those spikes occurred just because this event might happen, imagine when it actually does. Everything else until then is just noise

FI_PF_

Last year HHS recommended to DEA to reclassify in September but there was so much FUD in that sector that people didn’t believe it would happen

No_Love_Gained

I have almost 300k at that average and am excited about today's move. Can't wait to scale back to HHS highs. Glta

UsedState7381

Garland memo and then uplisting are far more important to us than SAFER. With this being said, making money is the name of the game and it's why we are all here, I'm not gonna fault you for that at all. As for me, I held it when it went under $8 months after the HHS letter, bought like crazy to get my average down to $8, so now I'm okay with holding to see how the comment period will pan out because holding through S3 was far harder. But if I see my tjcker hitting over $50 withing this year will consider exiting it too...Making money is the name of the game.

-PsillyFunGuy-

🙋‍♂️ i’ve been literally all-in on weedstocks since the big dip after the HHS leak (after losing more than I will admit the two years prior). Been putting literally all of my liquid assets into weedstocks since then. Holy shit do I feel redeemed. I definitely had some weak moments there…still down a tad but I trust the morning gap-up will finally put me in the green Celebrating right now with a bowl and a beer. Cheers everyone, and congrats on making it through

greendoor_805

Today, we heard the welcome news that the DEA is agreeing with the HHS recommendation to move cannabis from Schedule I to Schedule III.  Boris Jordan, Executive Chairman of Curaleaf, joins at the top of the show to share his thoughts on the next steps in the process, the timing of a final ruling, potential risks along the way,  implications for institutional interest, and the specific impact of 280E on Curaleaf's business.  Hirsh Jain, founder of Ananda Strategy, joins for the second half and helps us better understand the similarities between cannabis's path to legalization and what happened with gay marriage. He also gives his perspective on the time frame for the DEA final ruling, advances in medical research, and how Schedule III may impact state election outcomes. We close by asking Hirsh his biggest concerns about this process and potential stumbling blocks.  

UsedState7381

Because the market is irrational and people wanted to pump whatever weedstock was the most accessible at the time and not everyone has access to the OTC market. Not for nothing, whoever was stupid enough to buy into TLRY from back then AND held through out up until today, is still heavily underwater because it's a shitty company ran by a shady CEO that loves to huy worthless smaller companies and dilute shares whenever it runs up. Also, the own fucking CEO said, a few months after the HHS letter, that rescheduling wouldn't really fundamentally change the stock at all. If you still think that said company is still worth investing long term, even after that, then  I can only ask you to post the loss porn once this run up eventually fades away again.

john2557

Why is MSOS -2% in after hours? During the HHS rally last year, I remember that every stock still continued to rally significantly in AH's...

djshotzz504

MSOs ran 88% in 8 days in October off just the HHS recommendation.

agedoak31

It’s going to be bigger than the HHS leak. I think that was nine days or something

Budshawz

Do you happen to know what the premium looked like on the HHS announcement?

trebuchetty1

Just a reminder that even after the HHS leak back in Aug '23 we didn't go up more than 23% on a single day. During the HHS leak MSOS (using as a sector average) went up almost 100%, but it took 2 weeks to get there. The first couple days of the HHS leak looked like: +21%, +15%, +1%, +18%, etc... It's highly likely we can expect something similar here. SO, IF YOU THINK YOU'VE MISSED THE OPPORTUNITY, YOU HAVEN'T. WE'RE JUST GETTING STARTED!!!!!

Budshawz

The OLC opinion is the formal legal opinion of the DOJ. So let's say for example HHS asks "Can the DEA disagree with the medical data that we present them?" if the OLC comes back and says no they can't, the DEA is not allowed to disagree with that - thats how its binding. That being said, its not very useful until we know what was asked and what the response was.

Many_Easy

To quote Schroyer on February 2nd, 2024 “this month, maybe next month.” Similar quotes from many others on all sides of political spectrum and cannabis “media.” Just noise at this point and nothing concrete other than HHS recommendation and redacted release many moons ago.

nfisherzz

Got in a lot later than most people, got in right around the time HHS made the recommendation. Been holding HITI, CURLF, trulieve, and cresco.

KAI5ER

I should have known something was up when HHS news came out and a huge emphasis was placed on "THE DEA HAS FINAL SAY" It just reeks of conflict.

bananastock

This sector is literally rotten. Entire market is green, vix is low, and this sector just bleeds. Here we are 8 months after HHS and no news from the DEA. Can't wait for concrete news to gtfo. Someone asked, given a second chance, would you still invest in the sector? Monekys could have literally thrown a dart and done better than anyone holding these companies stocks.

greenbelieve

Yeah I’m still here, we’re just in the dog days of DEA currently so even though there’s “lots” to talk about, there’s really nothing to talk about…unless we just wanna talk about talking. It’s exhausting day in/out to see what this bi-polar sector blows out of proportion (in a positive or negative direction). I think there is solid momentum occurring but no one who’s been around a while needs to bang that drum all the time. I’m optimistic for meaningful change this year, but for an OG like myself, it’s not just waiting since HHS, it’s waiting over 7 years for the politicians to do something meaningful. So although there are signals the time is near, it’s just more of the same…until it’s not. Then I’ll be here for the bread. We all will.

WilsonTradesMaui

My working timeline is June 19th based on the DEA person writing that “we are now reviewing the HHS recommendation” (paraphrasing) on Dec 19th and then a separate DEA person commenting that reviews can take from 3 to 6 months. If it’s not announced by the you are probably right.. unfortunately

UsedState7381

Would be a dream coming through, but nah, HHS recommended rescheduling to 3 and nothing else beyond that so I don't see we getting anything else.

Imaginary_Rooster622

You're not alone. This is pretty frustrating. Allegedly, Biden needs the young vote and cannabis is the vehicle for those votes. I guess we'll see. More like dangling carrots every day. However, that 225 page scientific review that supports HHS moving cannabis from 1 to 3 is ammunition in the event that this becomes one big rug pull. Litigation is not good for the stock price. Neither are Chuck and Kamalas theatrics with zero follow through. The million dollar question for me is: When is it strategically the best time for Biden to release S3? I say Biden and not Milgram because I believe it's all political. She's just waiting for the go ahead.

Fuego1050

My angle was that they just outlined what a regular process is. They referenced that 1977 ruling in one of the congressional letters as being outdated. Romney was wrong. The only thing OLC can say is that the treaty outlines the required regulations, but doesn’t bind DEA to a specific schedule. As well as, the need to respect HHS science/recommendation. If they follow the CSA carefully - as indicated - i still dont see why they would go through N and C - and just do epidiolex 2.0. Well see I guess. That DEA official march 28th said it was “an absolute unknown” as per public comment.

Budshawz

Definitely significantly lowers my confidence it will be a final order. Only reason to not put what they are going to do there would be if the departments are incompetent and don't really communicate with each other - which is a very real possibility with the government lol. Could be that the positive legal judgment said that HHS was binding and they have to reschedule to 3, but they also are bound by the process in section (b). Hopefully get some clarity on where exactly they are in the process next week when people can ask questions directly to people doing it. Or they'll just answer we can't talk about that.

mealucra

Man, only two trading days left after today for DEA to announce during second chance month... Been eight months since HHS handed over their work to DEA... #... 🐌

talktothepope

I figured out the reason TLRY doesn't move as much as the other LPs. Seems pretty obvious now. TLRY has a 2b CAD market cap, but only like 1/3 of their revenues are from cannabis. Meanwhile, ACB (for example) is pretty much purely cannabis revenue, for currently a 500m MC. TLRY has a bit more cannabis revenue (rough math, about 20% more), but not 4x more which is the current difference in their market caps. So ACB and the others are "pure plays" moreso than TLRY and it makes sense that they would move first. If there's an actual catalyst, I think TLRY could pump bigly, but until then it is what it is. Cannabis revenue per million of market cap might be a good stat to look at here. And no, it's not the R/S or the "tight float" no matter how often that gets repeated, because these companies did the same damn pump after the HHS letter news, before they did their R/S

badgebruce

S3 has the science behind it. HHS and FDA support S3. What's up with the DEA politics?

Throwing_Horns

^(If were playing that game...May 21-23 days before Memorial Day weekend. A Monday holiday emphasizes news impact with extra friends and family time to really spread like a dinner table sneeze.) [^(Like the HHS did when announcing their review before Labor Day 2023.)](https://www.cnn.com/2023/08/30/health/marijuana-schedule-hhs-dea/index.html) [^(On the other hand the Ye Ol' Farmer's Almanack says that we are safely out of Mercury retrograde today.) ](https://www.almanac.com/content/mercury-retrograde-dates)^(For the sum of all it's worth.)

Unlikely-Bullfrog-92

We must add to your list the most recent letter some Senators sent to DEA to remind them that a long time has passed since HHS recommended S3.

TuffNutzes

Anne and her cronies holding this up against lawsuits, letters from Congress, roundtables with the VP and SOTU addresses by the president himself never mind HHS already telling her what to do based on science and fact. The only logical explanation is Anne is short big time on all the MSOs.

Fuego1050

A few weeks ago - the DEA interviewer said it was unknown whether it was final order or notice and comment, So as of 16th - the process has moved along - they are acknowledging a NPR for re-schedule. Which means they may interpret that cannabis is “already controlled” and so it doesnt “require” control based on international treaty. They acknowledge HHS recom is to be taken into consideration and regulations there forth (treaty). When they did all the regulations changes for cannabis in 2018 - it required NPRM. By all accounts - they are on the very home stretch. Ample time to December for a final rule. OLC and HHS is legally binding.

Fuego1050

They have 8 mths - they can be done by yr end - not by november. Biden still in power until early jan. But its legal….. and OLC opinion and HHS opinion are binding on DEA. So once the process is far along - its over for a final decision to 3

Many_Easy

Thank you! You are **correct** about Zorn doing the work. If he hadn’t, someone else would have likely gotten the HHS files, but yes he was the first and deserves **kudos** for his efforts. Zorn actually got us something “concrete” and “actual.” **Zorn didn’t deserve the lumping in with the other rumormongers and engagement farmers.**

slobjones11

Without Matt Zorn's legal work, you would not have the public HHS recommendation. Lumping him in with MAGAt crap-mongers is absurd and unfair.

Fuego1050

New DEA letter: april 16th to the democrats: Thank you for your January 29, 2024, letter regarding your interest in the scheduling of marijuana. We appreciate the opportunity to receive your concerns and questions. For the Department of Justice (Department), and by delegation the Drug Enforcement Administration (DEA), to take an administrative scheduling action, it must follow the procedures that Congress set forth in the Controlled Substances Act, including an opportunity for a public comment period and a hearing. The Department of Justice is carefully following those procedures as it conducts an administrative review of the scheduling of marijuana. On August 29, 2023, DEA received a letter from the Department of Health and Human Services (HHS) providing its findings and recommendation on marijuana scheduling, pursuant to President Biden's request for an administrative review. As part of this process, HHS first conducts a scientific and medical evaluation, and then DEA conducts its own review. DEA has the final authority under this administrative path to reschedule a drug under the Controlled Substances Act, after considering relevant statutory and regulatory criteria and HHS' scientific and medical evaluation. ****+++** NB- statutory/regulatory = treaty regulations and HHS science being incorporated = S3. If not a final order…. Then this needs to come out asap…. Now is the time DEA - do it

trebuchetty1

>In other words, stocks could go up or down or sideways. Damn. You're good! ;) My, admittedly poor, understanding of that premium existing typically means decent inflows, does it not? Usually ItinerantDrifter comments about this during his most excellent eod posting. DEA S3 news could always go the way of the HHS leak (comes out of nowhere), but given the political nature of this and all the other political maneuvering going on regarding cannabis, I struggle to understand how this won't end up being a case of "Someone knows something", where a couple days to a couple weeks prior the inflows just start coming in hot and consistently growing until we hit the news and launch. Loose lips and all. No way Soonmer isn't going to want to make a massive amount of money on this (directly or indirectly).

Unaphotobomber

Anne's been high as fuck since HHS leak, she's finally coming down enough to announce this week?

More_Advertising_383

Yeah, I personally I don’t think that means a thing at all. I’m more in the school of thought that the next catalyst is the FAA bill with SAFE attached and that s3 will happen in the summer (dragging their feet as long as possible / 6months after the HHS 252 page report was published / enough time for it to progress and be boasted as a win for the election). Second chances to mean are pardons and expungements. I fail to see our S3 is a second chance when I’ve lost count of the chances for any meaningful reform. Just my two cents.

bananastock

So the may 17 options chain is absolutely insane with tons of open interest right to the top at 20 on the calls. We are below 98% of the OI on the call side. On the put side we have 10k at 8, 14k at 7, 5k at 6 and 12k at 9. There are a ton more calls than puts. It hasn't meant anything in the past. We've never had a gamma squeeze forcing prices up besides 1 or 2 months since HHS last Aug, if my memory serves me well.

Fuego1050

- march 15th doug kass - “We have learned yesterday that the US Drug Enforcement Administration will shortly approve a rescheduling of cannabis to Schedule Ill --and that the biggest legal hurdle, an international treaty” - april 17th Anthony verall- My sources tell me the OLC legal opinion requested by the HHS is done and ready to be published. It’s also validating the HHS recommendation and in our favor regarding rescheduling. $MSOS DEA was charged by WH to have completed by end of q1. So their recommendation and document would be largely completed. Adjusting for regulations given OLC opinion….. and then 1-2 weeks after Anne signs the document - it will be published on the registrar. SAM was worried it was to be approved any day a few weeks ago. We’ve never been closer - and each day that passes - this statement becomes more true - not less.

DEASqueezeAllComing

You missed the live stream of copium! We were all gathered and listened to titanic flute song while feasting on Kraft dinner and sipping tap water. Then we listened to the song that goes : Are you okay ? Are you okay? Are you okay Anne Milgram? Put an end to short selling smooth criminals On a more serious note, now that's it more quiet and all the dates predicted or rumoured are behind us, I like our chances given Biden mentionned HHS review during SOTU in March and made a 4/20 twitter post. It's only a matter of when , not a if!

More_Advertising_383

235 since leak, 110 since the 252 page HHS report was released/published. The DOJ and this entire administration can go fuck itself.

p3pp3rjack

How many days has it been since the HHS release/leak?

Throwing_Horns

HHS went the week before Labor Day weekend 2023. I'd venture to guess DEA might go leading into Memorial Day weekend 2024, probably May 21-23. This is just a guess based on the correlation of Labor Day and Memorial Day being long weekend Monday holidays. People have an extra day to chatter with their friends and relatives near the end of the month. ^(Tomorrow would be a random day, that would be best, I agree.)

talktothepope

The last arbitrary date was the 29th (HHS). I'd be happy with that.

DirtyBirdie99

They aren’t going to do it at any time that is significant. They will drop it on a random day. To think otherwise is just not realistic. The administration has been clear that it is out of their hands, so why would the DEA then drop it on some planned date… it would make the admin look like they were lying. So let’s stop trying to postulate like we know when its going to happen. I’d also like to say that I think that Don Murphy’s theory on a Friday before a recess is ridiculous. Why would it need to be the Friday? It could be any day during the recess based on his theory. Also, if the admin was pulling the strings, they wouldn’t hide it during a recess. I just think its going to drop at a random time just like the HHS announcement. So let’s stop trying to time it. It was obvious it wasn’t happening for 4/20.

Tiaan

WH press sec was asked again about rescheduling cannabis and gave the same response, eg "HHS finished their independent review based on science, and now it's under review at DOJ. All questions regarding status/timing of rescheduling should be made towards DOJ"

badgebruce

HHS has recommended S3. FDA agrees with S3. What is going on with the DEA?

badgebruce

FDA states cannabis should be S3 just like the HHS recommended. What is the hold up?

talktothepope

Ugh, you realize CGC ran the same damn way on HHS news before their RS right? I don't know what the difference is, but it ain't the RS

MonsterDrunk

lol SAFE, DEA, S3, OLC, HHS all acronyms I am going to be scrawling in my own blood on the wall of my asylum cell

RandomGenerator_1

Date: 2018, June6th Licensing Marijuana Cultivation in Compliance with the Single Convention on Narcotic Drugs https://www.justice.gov/olc/file/1272131/dl We conclude that DEA must alter the marijuana licensing framework to comply with the Single Convention. ... At a minimum, however, this licensing framework must provide for a system in which DEA or its legal agent has physical possession and ownership over the cultivated marijuana and assumes control of the distribution of marijuana no later than four months after harvesting. ... For instance, DEA could station one or more employees at the National Center after cultivation as a way of ensuring physical possession of the marijuana and exclusive control over its distribution. ... The Single Convention does not require that a single government agency be charged with all responsibilities related to marijuana, and the congressional decision to delegate those responsibilities to HHS is consistent with the Single Convention. .... But the practices of a handful of the 186 parties to the treaty are entitled to comparatively little weight in illuminating the meaning of the treaty, and certainly do not supply the kind of subsequent practice that “establishes the agreement of the parties regarding its interpretation.” _________________________ Some parts out of the analysis by the OLC in 2018. The main issue seemed to be that the Federal Government needs to take physical posession of marijuana. Also they compared to other countries, but there wasn't a clear approach back then. Germany changed that in the mean time. If I link the above with the FDA budget request of 2025. I do see them asking for money to do more onsite inspections and also for foreign facilities.

Blistorious

So OLC is now the the new DEA, S3, HHS, SAFE.. fully prepared to read those three letters the next weeks or even months. That emergency press conference was so cringe. A trustworthy person blabla.. well, how many time did we hear that in the last years? And then.. if we don't get anything we're fucked.. lol yeah seriously?! As always nobody knows shit. The day I can forget about all those capital letters, Schumer, Booker and all those crooks from Pablo to those Dan's, will be Christmas and birthday together.

talktothepope

Wasn't he the most on the ball when it came to the HHS letter?

Tiaan

I've asked my good friend AI to explain the significance of the OLC news today: **Significance of OLC Opinion Completion in Timeline:** The completion of an OLC opinion in this context would be significant for several reasons: * **Policy Implementation:** The completion of an OLC opinion can be seen as a green light for HHS and DEA to proceed with the rescheduling process. It would confirm that the proposed action does not violate existing laws and is procedurally sound. * **Public and Political Perception:** Official confirmation that the OLC has completed its review and supported the action can lend credibility and legal legitimacy to the rescheduling effort. It might also influence public opinion and the positions of lawmakers, potentially affecting legislative support or opposition. * **Predictability of Timeline:** Knowing that the OLC has completed its review provides a clearer timeline for the next steps in the rescheduling process. Following the OLC's opinion, the DEA would typically initiate rule-making procedures, including public notice and comment periods, before finalizing the rescheduling. This makes the timeline more predictable for stakeholders, including businesses, state governments, and advocacy groups. Thus, the OLC's involvement and the completion of its legal opinion are crucial steps in ensuring that the rescheduling of cannabis is legally defensible and procedurally correct, setting the stage for formal regulatory actions.

RandomGenerator_1

Because HHS covers the medical and scientific side. The only thing the DEA can be difficult about is the legal stuff. So HHS kinda found a way around that to be sure. If the OLC doesn't find any legal troubles, the DEA has no reason to offer a resistance anymore. The missing key here is: what legal advice did HHS ask for?

mr_molecular

I don’t think so, I think the DEA would also ask HHS to reconsider 3 if they wanted to decriminalize.

goalpost21

But would we know that if they did ask HHS to reconsider?

mr_molecular

The DEA cannot reschedule to 2, without first asking HHS to reconsider their recommendation of 3.

GrittyofBrotherlyLuv

"My sources tell me the OLC legal opinion requested by the HHS is done and ready to be published. It’s also validating the HHS recommendation and in our favor regarding rescheduling. $MSOS" https://twitter.com/V_arrell/status/1780636940703817748

SV_art

Honest question, why does this even matter? HHS has already provided their recommendation, why do they need to provide a legal opinion? I feel like it'll just same the same stuff and we'll again be waiting for DEA.

bananastock

Anthony from The Dales says HHS legal opinion is ready to be published. Probably legit but timing is suspect. Everyone holding would like a gamma squeeze. We'll see if the market makers will let it happen or if volume over powers the MM.

pop2012

"The sources also said that HHS officials have recently requested information from the Justice Department’s Office of Legal Counsel (OLC) on the legal implications of marijuana rescheduling." "While the Journal report doesn’t specify what legal consideration HHS has asked DOJ’s OLC to weigh in on, it’s possible that it’s related to international policy implications of rescheduling amid conflicting opinions." -MM article from March 11, 2024

SailMaleficent6183

By HHS??? Someone please fill me in what this was about?

livefromheaven

"My sources tell me the OLC legal opinion requested by the HHS is done and ready to be published. It’s also validating the HHS recommendation and in our favor regarding rescheduling. $MSOS" https://twitter.com/V_arrell/status/1780636940703817748

Old-Outside6894

Great strategy. I used this until recently. I kept a long position and slowly traded each pump since HHS to lower my average and increase cash. I’m now close on all my stocks and have 50% cash to deploy either for a trade (long way down from here) or REAL catalyst. Best wishes.

Purple-Leopard-6796

By that same logic, why was fall 2023 HHS announcement not priced in? 

Purple-Leopard-6796

Everyone negative. Good. Wasn’t everyone negative before HHS dropped new last fall, and Msos price doubled in couple of weeks ?

DonJohnson108

Literally nothing new was said today by the White House Press Secretary. She said HHS and AG were directed to review. HHS concluded its independent review. And now the review is in the hands of the DOJ (which the DEA is a part of). So how is that an update that the HHS has concluded its review and the DOJ (DEA) is still reviewing. My minds blown by this informative update.

MidWestFineese

I feel like HHS to DEA, DEA to DOJ (basically giving completed paperwork to your boss for approval) for announcement..

AmbassadorCosh

"I will give you a little bit of an update" "As you all know....Biden...HHS...DOJ" Yes we do all know, now where is the update?

Tiaan

This "update" is really a nothingburger. She has always referred to the larger, parent departments involved in rescheduling (HHS and DOJ) rather than the smaller departments (FDA and DEA) who are actually doing the work. See this article from Aug 2023 https://www.marijuanamoment.net/top-federal-health-agency-says-marijuana-should-be-moved-to-schedule-iii-in-historic-recommendation-to-dea/ No mention of DEA at all, and she used similar language to today: > administrative process is an independent process led by HHS and DOJ and guided by the evidence... And so I’m going to leave it to HHS and DOJ to move that process Today she just reiterated what we already know, that it's under review within the DOJ (at the DEA)

Fifteen_inches

I’m with you. I don’t think that there is anything for us to worry about. It’s an election year, Biden needs a win, HHS made its recommend, there is nothing to review. At worst the DEA is dragging its heels on purpose, and at best Biden is holding back S3 for political points. I don’t see a world where S3 doesn’t happen.

slobjones11

Shane Pennington says S3 review process could take "years" to finalize, even if DEA proposes the change. Pennington and Matt Zorn are responsible for release of the HHS document, so discount his view at your own peril. https://x.com/Johnschroyer/status/1779886071683166569

slobjones11

Shane Pennington says S3 review process could take "years" to finalize, even if DEA proposes the change. Pennington and Matt Zorn are responsible for release of the HHS document, so discount his view at your own peril. https://x.com/Johnschroyer/status/1779886071683166569

thedmob

I don’t think MSO traded down for any reason other than macro stuff. Cura was down a ton the couple days before HHS news.

shitmodsmustdie

Nobody would have known that it was happening until Biden commanded the HHS do their review.  And nobody is paying that close attention.  They mapped out the process, they figured it is two years from start to finish.  They pulled the trigger in 2022 and now the train arrives when the train arrives.  There is nothing to complain about.  Everybody in DC understands bureaucracy

RandomGenerator_1

Yes that's about FDA approval. But the fact that HHS already made their Schedule 3 recommendation lets us know we are passed this upheaval.

Imaginary_Rooster622

I was thinking about this the other day. Is it realistic to think that Anne Milgram is waiting for Biden to call her and say " Coast is clear, release the news ". I don't think so. I think the date and time for the DEA to accept HHS's recommendation for rescheduling is already booked. What do you think 🤔

bigsilverhotdog

If DEA announces this week the reaction will be unbelievable because the market currently has few bull concepts to throw money at and a broader correction has likely just begun. It might seem counterintuitive but this would actually be the best possible time in the entire last 6 months to get this news we've all been waiting for. Remember that the HHS announcement came as the wider market was undergoing a correction and the current rally has been significantly bigger and stronger than the 2023 tech rally that fed the HHS rally. If history repeats again the result this time around for the cannabis sector would be legendary. **Legendary.**

TuffNutzes

So the HHS/FDA, who are the doctors and scientists looking out for the health of Americans have determined that S1 for cannabis is a ridiculous travesty, even abzurd one (VP) might say. And the DEA, who are just enforcers/cops and nothing more, whose job is to listen to lawmakers, doctors and scientists and enforce laws and policies. PERIOD. We're not paying you to THINK, DEA. You are the muscle. Know your place and stay in your lane and do what you're told.

ivigilanteblog

Yeah, I doubt they will suggest bifurcating the scheduling on a use basis since that has never been done before and it would lead to all sorts of strange, confusing problems for the industry, users, and law enforcement. But, if they do make that mistake, I expect legalization proponents to scream very loudly that the only sensible fix is to deschedule and legislate control of the cannabis plant like we did with alcohol and tobacco. Which is really the result we want, anyway. That outcome, while it would be painful in the short term, is probably preferable to two other possible outcomes: DEA recommending S2 or asking HHS to reconsider. If they do either of those, we probably stall in federal legalization efforts for years. If they do S3, we probably leap forward, and we definitely experience many benefits. If they recommend something lower, like S4-5 or descheduling, then we experience a moonshot on the sector and we get a ton of other social/legal benefits right away.

ivigilanteblog

It does not, in this case. Congress delegated scheduling authority to HHS/DEA. Biden already took one appropriate path to re/descheduling without Congressional input, and that was his directive to those agencies to review the scheduling of cannabis. He could also have issued an executive order to re/deschedule, but he did not and no president is likely to due to legal challenges to the authority (which I think would fail, but they would definitely happen).

thedmob

I dont think that is likely. Anything is possible. Remember we pulled back twice in this run already. If they come back with anything other than schedule 3. Including asking the HHS to reconsider I agree we will hit new ATL. I personally have conviction DEA is going to do what they have been told to do by HHS so I am holding with confidence.

noobstockinvestor

I got downvoted to oblivion for saying SAFER is more important than schedule 3. SAFER is harder to reverse since its an act of congress. The next trump AG can overturn anything Biden does. There is still a lot of uncertainty. Any cover HHS/DEA/DOJ gives us, a similar result can be obtained from the Boise lawsuit. Going through the courts has more staying power if Biden loses the next election.